A. Oseroff

发表

Photodynamic therapy for non-melanoma skin cancer.

Sari Fien, A. Oseroff, 2007, Journal of the National Comprehensive Cancer Network : JNCCN.

Photofrin photodynamic therapy can significantly deplete or preserve oxygenation in human basal cell carcinomas during treatment, depending on fluence rate.

Michele T. Cooper, W R Greco, D Babich, 2000, Cancer research.

Basal cell and squamous cell skin cancers.

A. Oseroff, N. Lee, J. Grichnik, 2010, Journal of the National Comprehensive Cancer Network : JNCCN.

Femtosecond optical ranging in biological systems.

J. Fujimoto, A. Oseroff, E. Ippen, 1986, Optics letters.

A murine monoclonal antibody (VM-1) against human basal cells inhibits the growth of human keratinocytes in culture.

E. Pfendt, A. Oseroff, V. Morhenn, 1985, The Journal of investigative dermatology.

IL-10 Does not Play a Role in Cutaneous Photofrin® Photodynamic Therapy-induced Suppression of the Contact Hypersensitivity Response¶

B. Henderson, A. Oseroff, S. Gollnick, 2001 .

The Anatomic Site of Photodynamic Therapy is a Determinant for Immunosuppression in a Murine Model

A. Oseroff, D. Musser, S. Camacho, 1999, Photochemistry and photobiology.

Rapid-flow resonance Raman spectroscopy of photolabile molecules: rhodopsin and isorhodopsin.

A. Oseroff, L. Stryer, R. Mathies, 1976, Proceedings of the National Academy of Sciences of the United States of America.

Fluorinated photosensitizers: synthesis, photophysical, electrochemical, intracellular localization, in vitro photosensitizing efficacy and determination of tumor-uptake by 19F in vivo NMR spectroscopy

A. Oseroff, K. Ohkubo, S. Fukuzumi, 2003 .

GRP78 Induction by Calcium lonophore Potentiates Photodynamic Therapy Using the Mitochondrial Targeting Dye Victoria Blue BO

A. Oseroff, J. Morgan, J. Whitaker, 1998, Photochemistry and photobiology.

MULTIPLE MODALITY TREATMENT OF CARCINOMA CELLS WITH Pt(Rh‐123)2 PLUS X‐RAY PLUS LIGHT

A. Oseroff, B. Teicher, T. Herman, 1992, Photochemistry and photobiology.

Synthesis, comparative photosensitizing efficacy, human serum albumin (site II) binding ability, and intracellular localization characteristics of novel benzobacteriochlorins derived from vic-dihydroxybacteriochlorins.

T. Dougherty, A. Oseroff, R. Pandey, 2003, Journal of medicinal chemistry.

Chlorophyll-a analogues conjugated with aminobenzyl-DTPA as potential bifunctional agents for magnetic resonance imaging and photodynamic therapy.

Lalit N. Goswami, A. Oseroff, R. Pandey, 2005, Bioconjugate chemistry.

Methyl pyropheophorbide-a analogues: potential fluorescent probes for the peripheral-type benzodiazepine receptor. Effect of central metal in photosensitizing efficacy.

Amy L. Gryshuk, T. Dougherty, A. Oseroff, 2005, Journal of medicinal chemistry.

Laser and photodynamic therapy in the management of cutaneous malignancies.

A. Oseroff, N. Zeitouni, S. Shieh, 2001, Clinics in dermatology.

Monoclonal antibody―chromophore conjugates as selective phototoxins

T. Hasan, A. Oseroff, M. Yarmush, 1989 .

Comparative positron-emission tomography (PET) imaging and phototherapeutic potential of 124I- labeled methyl- 3-(1'-iodobenzyloxyethyl)pyropheophorbide-a vs the corresponding glucose and galactose conjugates.

A. Oseroff, R. Pandey, Yihui Chen, 2009, Journal of medicinal chemistry.

A First Comparative Study of Purpurinimide-based Fluorinated vs. Nonfluorinated Photosensitizers for Photodynamic Therapy¶

T. Dougherty, W. Potter, A. Oseroff, 2002 .

The Tyrosine Kinase Inhibitor Imatinib Mesylate Enhances the Efficacy of Photodynamic Therapy by Inhibiting ABCG2

A. Oseroff, J. Morgan, M. Baer, 2007, Clinical Cancer Research.

Prognostic factors and evaluation of mycosis fungoides and Sézary syndrome.

A. Oseroff, J. Toro, P. Stomper, 1997, Journal of the American Academy of Dermatology.

Functionalization of OEP-based benzochlorins to develop carbohydrate-conjugated photosensitizers. Attempt to target beta-galactoside-recognized proteins.

Amy L. Gryshuk, A. Oseroff, A. Gryshuk, 2004, The Journal of organic chemistry.

Purpurinimide carbohydrate conjugates: effect of the position of the carbohydrate moiety in photosensitizing efficacy.

T. Dougherty, B. Henderson, A. Oseroff, 2007, Molecular pharmaceutics.

Synthesis of beta-galactose-conjugated chlorins derived by enyne metathesis as galectin-specific photosensitizers for photodynamic therapy.

T. Dougherty, A. Oseroff, R. Pandey, 2001, The Journal of organic chemistry.

In vivo stability and photodynamic efficacy of fluorinated bacteriopurpurinimides derived from bacteriochlorophyll-a.

W. Potter, A. Oseroff, A. Gryshuk, 2006, Journal of medicinal chemistry.

Water soluble, core-modified porphyrins. 3. Synthesis, photophysical properties, and in vitro studies of photosensitization, uptake, and localization with carboxylic acid-substituted derivatives.

Tymish Y. Ohulchanskyy, A. Oseroff, I. Roy, 2003, Journal of medicinal chemistry.

Photosensitizing dyes for the selection of nontumorigenic revertants from human lung cancer cell lines.

A. Oseroff, C. Harris, D. Brash, 1990, Cancer research.

THE USE OF TETRAZOLIUM SALTS TO DETERMINE SITES OF DAMAGE TO THE MITOCHONDRIAL ELECTRON TRANSPORT CHAIN IN INTACT CELLS FOLLOWING in vitro: PHOTODYNAMIC THERAPY WITH PHOTOFRIN II

A. Oseroff, D. Musser, 1994 .

THE USE OF TETRAZOLIUM SALTS TO DETERMINE SITES OF DAMAGE TO THE MITOCHONDRIAL ELECTRON TRANSPORT CHAIN IN INTACT CELLS FOLLOWING in vitro PHOTODYNAMIC THERAPY WITH PHOTOFRIN II

A. Oseroff, D. Musser, 1994, Photochemistry and photobiology.

Characteristics of the Immunosuppression Induced by Cutaneous Photodynamic Therapy: Persistence, Antigen Specificity and Cell Type Involved ¶

A. Oseroff, D. Musser, 2001 .

Antineoplastic activity, synergism, and antagonism of triarylalkylphosphonium salts and their combinations.

A. Oseroff, D. Rideout, T. Calogeropoulou, 1994, Anticancer research.

A pulsed electric field enhances cutaneous delivery of methylene blue in excised full-thickness porcine skin.

A. Oseroff, S. Hui, S. Gallo, 1998, The Journal of investigative dermatology.

Synthesis and evaluation of chalcogenopyrylium dyes as potential sensitizers for the photodynamic therapy of cancer.

A. Oseroff, S. Gollnick, S. Gibson, 1999, Journal of medicinal chemistry.

Dermatofibrosarcoma protuberans.

A. Oseroff, N. Lee, J. Grichnik, 2022, Journal of the National Comprehensive Cancer Network : JNCCN.

Selective enrichment of human epidermal cell subpopulations using monoclonal antibodies.

A. Oseroff, E. Engleman, G. Wood, 1983, The Journal of investigative dermatology.

ALA-PDT in dermatology Results and mechanisms

A. Oseroff, J. Morgan, D. Wagner, 1996 .

Structure–Activity Relationship of New Octaethylporphyrin‐based Benzochlorins As Photosensitizers for Photodynamic Therapy ¶

T. Dougherty, A. Oseroff, R. Pandey, 2003, Photochemistry and photobiology.

Irradiation of pigmented melanoma cells with high intensity pulsed radiation generates acoustic waves and kills cells

A. Oseroff, G. Ara, Rox R. Anderson, 1990, Lasers in surgery and medicine.

Water-soluble, core-modified porphyrins as novel, longer-wavelength-absorbing sensitizers for photodynamic therapy.

A. Oseroff, S. Gollnick, S. Gibson, 2000, Journal of medicinal chemistry.

A First Comparative Study of Purpurinimide‐based Fluorinated vs. Nonfluorinated Photosensitizers for Photodynamic Therapy ¶

T. Dougherty, W. Potter, A. Oseroff, 2002, Photochemistry and photobiology.

Comparison of Photodynamic Targets in a Carcinoma Cell Line and Its Mitochondrial DNA-Deficient Derivative

W. Potter, A. Oseroff, J. Morgan, 2000, Photochemistry and photobiology.

A Mechanism for the Oxidation of Glutathione to Glutathione Disulfide with Organotellurium(IV) and Organoselenium(IV) Compounds. A Stepwise Process with Implications for Photodynamic Therapy and Other Oxidative Chemotherapy

A. Oseroff, M. Detty, A. Friedman, 1994 .

Monoclonal Antibodies to Human Lymphocytes

A. Oseroff, D. Maloney, M. Link, 1984 .

Water-soluble, core-modified porphyrins as novel, longer-wavelength-absorbing sensitizers for photodynamic therapy. II. Effects of core heteroatoms and meso-substituents on biological activity.

Russell Hilf, Gary A Baker, Frank V Bright, 2002, Journal of medicinal chemistry.

A selenopyrylium photosensitizer for photodynamic therapy related in structure to the antitumor agent AA1 with potent in vivo activity and no long-term skin photosensitization.

A. Oseroff, S. Gollnick, S. Gibson, 2000, Journal of medicinal chemistry.

Synthesis and photosensitizing efficacy of isomerically pure bacteriopurpurinimides.

T. Dougherty, B. Henderson, A. Oseroff, 2004, Journal of medicinal chemistry.

The Tyrosine Kinase Inhibitor Imatinib Mesylate Enhances the Efficacy of Photodynamic Therapy by Inhibiting ABCG2

Janet Morgan, Paula Pera, Xiang Zheng, 2007, Clinical Cancer Research.

The cell surface membrane: biochemical aspects and biophysical probes.

A. Oseroff, P. Robbins, M. Burger, 1973, Annual review of biochemistry.

Mitochondria-based photodynamic anti-cancer therapy.

A. Oseroff, J. Morgan, 2001, Advanced drug delivery reviews.

New approaches to photochemotherapy: cationic sensitizers and multi-agent combination therapies

Allan R. Oseroff, A. Oseroff, 1990, Other Conferences.

Structural modifications of plumieride isolated from Plumeria bicolor and the effect of these modifications on in vitro anticancer activity.

A. Oseroff, A. Gryshuk, R. Pandey, 2004, The Journal of organic chemistry.

Photosensitizers Derived from 132-Oxo-methyl Pyropheophorbide-a: Enhanced Effect of Indium(III) as a Central Metal in In Vitro and In Vivo Photosensitizing Efficacy

Tymish Y. Ohulchanskyy, Lalit N. Goswami, A. Oseroff, 2006, Photochemistry and photobiology.

Mitochondrial toxicity of cationic photosensitizers for photochemotherapy.

A. Oseroff, J. Modica-Napolitano, J. Joyal, 1990, Cancer research.

Raman Scattering from Localized Magnetic Excitations in Ni 2+ - and Fe 2+ - Doped MnF 2

A. Oseroff, P. Pershan, 1968 .

Photodynamic therapy for nonmelanoma skin cancers. Current review and update.

A. Oseroff, N. Zeitouni, S. Shieh, 2003, Molecular immunology.

Characteristics of the Immunosuppression Induced by Cutaneous Photodynamic Therapy: Persistence, Antigen Specificity and Cell Type Involved¶

A. Oseroff, D A Musser, A R Oseroff, 2001, Photochemistry and photobiology.

Use of a murine monoclonal antibody which binds to malignant keratinocytes to detect tumor cells in microscopically controlled surgery.

A. Oseroff, V. Morhenn, R. Roth, 1983, Journal of the American Academy of Dermatology.

Ceramic-based nanoparticles entrapping water-insoluble photosensitizing anticancer drugs: a novel drug-carrier system for photodynamic therapy.

Indrajit Roy, Janet Morgan, Tymish Y. Ohulchanskyy, 2003, Journal of the American Chemical Society.

Antigen specific and nonspecific modulation of the immune response by aminolevulinic acid based photodynamic therapy.

A. Oseroff, J. Morgan, K. Rittenhouse‐Diakun, 1998, Immunopharmacology.

Photodynamic therapy with methyl aminolevulinate for primary nodular basal cell carcinoma: results of two randomized studies

A. Oseroff, A. Menter, D. Murrell, 2009, International journal of dermatology.

Treatment of diffuse basal cell carcinomas and basaloid follicular hamartomas in nevoid basal cell carcinoma syndrome by wide-area 5-aminolevulinic acid photodynamic therapy.

A. Oseroff, L. Blumenson, R. Cheney, 2005, Archives of dermatology.

Aminolevulinic acid photodynamic therapy for skin cancers.

A. Oseroff, Jonathan E Blume, Allan R Oseroff, 2007, Dermatologic clinics.

Primary Basal Cell Carcinoma

A. Oseroff, N. Zeitouni, 2004 .

Resonance Raman spectroscopy of rhodopsin in retinal disk membranes.

A. Oseroff, R. Callender, 1974, Biochemistry.

Intramitochondrial dyes allow selective in vitro photolysis of carcinoma cells.

A. Oseroff, L. Cincotta, J. Foley, 1986, Proceedings of the National Academy of Sciences of the United States of America.

Resonance Raman Spectroscopy: Application of Tunable Lasers to the Study of the Molecular Mechanisms and Dynamics of Visual Excitation

A. Oseroff, L. Stryer, R. Mathies, 1976 .

Inhibition of lectin agglutinability by fixation of the cell surface membrane.

A. Oseroff, L. Sachs, C. Huet, 1973, Biochimica et biophysica acta.

Application of laser Raman spectroscopy to the structural analysis of polypeptides in dilute aqueous solution

A. Oseroff, J. Graham, D. Wallach, 1970, FEBS letters.

Nature: A rich source for developing multifunctional agents. tumor‐imaging and photodynamic therapy

Amy Gryshuk, Amy L. Gryshuk, Lalit N. Goswami, 2006, Lasers in surgery and medicine.

Enhanced Systemic Immune Reactivity to a Basal Cell Carcinoma Associated Antigen Following Photodynamic Therapy

A. Oseroff, G. Wilding, S. Gollnick, 2009, Clinical Cancer Research.

Comparison of Photodynamic Targets in a Carcinoma Cell Line and Its Mitochondrial DNA‐Deficient Derivative

W. Potter, A. Oseroff, J. Morgan, 2000 .

Immunological comparison of the usual and atypical human serum cholinesterase phenotypes

A. Oseroff, O. Lockridge, H. W. Eckerson, 1983, Biochemical Genetics.

Immunological comparison of the usual and atypical human serum cholinesterase phenotypes

A. Oseroff, O. Lockridge, H. W. Eckerson, 2004, Biochemical Genetics.

THE ROLE OF TRANSFERRIN RECEPTOR (CD71) IN PHOTODYNAMIC THERAPY OF ACTIVATED AND MALIGNANT LYMPHOCYTES USING THE HEME PRECURSOR δ‐AMINOLEVULINIC ACID (ALA)

A. Oseroff, G. Paszkiewicz, J. Morgan, 1995, Photochemistry and photobiology.

Photodynamic therapy for the treatment of extramammary Paget's disease

A. Oseroff, R. Cheney, N. Frawley, 2002, The British journal of dermatology.

Merkel cell carcinoma: Clinical practice guidelines in oncology™

A. Oseroff, N. Lee, J. Grichnik, 2006 .

Characterization of Endogenous Protoporphyrin IX Induced by δ‐Aminolevulinic Acid in Resting and Activated Peripheral Blood Lymphocytes by Four‐Color Flow Cytometry

A. Oseroff, C. Stewart, J. Morgan, 1998, Photochemistry and photobiology.

A SIMPLE METHOD FOR THE PURIFICATION OF HUMAN PERIPHERAL BLOOD ANTIGEN PRESENTING CELLS (DENDRITIC CELLS, MONOCYTES/MACROPHAGES, AND B LYMPHOCYTES)

A. Oseroff, J. Morgan, K. Rittenhouse-Olson, 2002, Immunological investigations.

Photofrin photodynamic therapy for treatment of AIDS-related cutaneous Kaposi's sarcoma.

T. Mang, T. Dougherty, A. Oseroff, 1999, AIDS (London).

Unscheduled DNA synthesis in human skin after in vitro ultraviolet-excimer laser ablation.

A. Oseroff, J. Parrish, I. Kochevar, 1987, The Journal of investigative dermatology.

PDT as a cytotoxic agent and biological response modifier: Implications for cancer prevention and treatment in immunosuppressed and immunocompetent patients.

A. Oseroff, Allan Oseroff, 2006, The Journal of investigative dermatology.

Irradiance-Dependent Photobleaching and Pain in δ-Aminolevulinic Acid-Photodynamic Therapy of Superficial Basal Cell Carcinomas

Thomas H Foster, Kenneth R. Keymel, T. Foster, 2008, Clinical Cancer Research.

Photodynamic Therapy Causes Cross-linking of Signal Transducer and Activator of Transcription Proteins and Attenuation of Interleukin-6 Cytokine Responsiveness in Epithelial Cells

Heinz Baumann, Allan R. Oseroff, A. Oseroff, 2004, Cancer Research.

Cytotoxicity and mutagenicity of low intensity, 248 and 193 nm excimer laser radiation in mammalian cells.

A. Oseroff, J. Parrish, I. Kochevar, 1987, Cancer research.

Compared to purpurinimides, the pyropheophorbide containing an iodobenzyl group showed enhanced PDT efficacy and tumor imaging (124I-PET) ability.

A. Oseroff, R. Pandey, Yihui Chen, 2009, Bioconjugate chemistry.

Selective ablation of atheromas using a flashlamp-excited dye laser at 465 nm.

R. Anderson, A. Oseroff, J. Parrish, 1986, Proceedings of the National Academy of Sciences of the United States of America.

Bacteriopurpurinimides: highly stable and potent photosensitizers for photodynamic therapy.

T. Dougherty, W. Potter, B. Henderson, 2002, Journal of medicinal chemistry.

Antibody-targeted photolysis: selective photodestruction of human T-cell leukemia cells using monoclonal antibody-chlorin e6 conjugates.

M L Yarmush, T. Hasan, A. Oseroff, 1986, Proceedings of the National Academy of Sciences of the United States of America.

A dose ranging study of photodynamic therapy with porfimer sodium (Photofrin®) for treatment of basal cell carcinoma

Michele T. Cooper, Michele Cooper, T. Mang, 2006, Lasers in surgery and medicine.

Mechanisms of Mitochondria! Photosensitization by the Cationic Dye, AVV'-Bis(2-ethyl-l,3-dioxylene)kryptocyanine (EDKC): Preferential Inactivation of Complex I in the Electron Transport Chain1

A. Oseroff, L. Cincotta, J. Foley, 2006 .

STRATEGIES FOR SELECTIVE CANCER PHOTOCHEMOTHERAPY: ANTIBODY‐TARGETED and SELECTIVE CARCINOMA CELL PHOTOLYSIS *

M L Yarmush, A. Oseroff, M. Yarmush, 1987, Photochemistry and photobiology.

Successful treatment of extramammary Paget's disease with imiquimod.

A. Oseroff, S. Shieh, T. Helm, 2003, Journal of drugs in dermatology : JDD.

Clinical Pharmacokinetics of the PDT Photosensitizers Porfimer Sodium (Photofrin), 2‐[1‐Hexyloxyethyl]‐2‐Devinyl Pyropheophorbide‐a (Photochlor) and 5‐ALA‐Induced Protoporphyrin IX

Hector Nava, T. Dougherty, H. Nava, 2006, Lasers in surgery and medicine.

Population pharmacokinetics of the photodynamic therapy agent 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a in cancer patients.

Hector Nava, Takaaki Tsuchida, T. Dougherty, 2003, Cancer research.

Mild skin photosensitivity in cancer patients following injection of Photochlor (2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a; HPPH) for photodynamic therapy

Hector Nava, Allan R. Oseroff, Thomas J. Dougherty, 2005, Cancer Chemotherapy and Pharmacology.

Tumor Vascular Response to Photodynamic Therapy and the Antivascular Agent 5,6-Dimethylxanthenone-4-Acetic Acid: Implications for Combination Therapy

A. Oseroff, M. Seshadri, R. Cheney, 2005, Clinical Cancer Research.

Multimodality agents for tumor imaging (PET, fluorescence) and photodynamic therapy. A possible "see and treat" approach.

Munawwar Sajjad, Amy L. Gryshuk, Janet Morgan, 2005, Journal of medicinal chemistry.

Photodynamic therapy mediates immediate loss of cellular responsiveness to cytokines and growth factors.

A. Oseroff, H. Baumann, E. Tracy, 2003, Cancer research.

Structure–Activity Relationship of New Octaethylporphyrin-based Benzochlorins As Photosensitizers for Photodynamic Therapy¶

T. Dougherty, A. Oseroff, R. Pandey, 2003 .

Mechanisms of mitochondrial photosensitization by the cationic dye, N,N-bis(2-ethyl-1,3-dioxylene)kryptocyanine (EDKC): preferential inactivation of complex I in the electron transport chain.

A. Oseroff, J. Bonventre, L. Cincotta, 1987, Cancer research.

Deletion of Alloantigen‐Activated Cells by Aminolevulinic Acid‐Based Photodynamic Therapy

A. Oseroff, J. Morgan, K. Rittenhouse‐Diakun, 1999, Photochemistry and photobiology.

PHOTOSENSITIZATION OF MURINE TUMOR, VASCULATURE and SKIN BY 5‐AMINOLEVULINIC ACID‐INDUCED PORPHYRIN

B. Henderson, A. Oseroff, D. Bellnier, 1995, Photochemistry and photobiology.

Organically modified silica nanoparticles with covalently incorporated photosensitizer for photodynamic therapy of cancer.

Indrajit Roy, Tymish Y. Ohulchanskyy, Lalit N. Goswami, 2007, Nano letters.

Structure-activity relationship among purpurinimides and bacteriopurpurinimides: trifluoromethyl substituent enhanced the photosensitizing efficacy.

Tymish Y. Ohulchanskyy, Lalit N. Goswami, W. Potter, 2007, Journal of medicinal chemistry.

A novel approach to a bifunctional photosensitizer for tumor imaging and phototherapy.

Britton Chance, Samuel Achilefu, Paras N Prasad, 2005, Bioconjugate chemistry.

Characterization of electric-pulse-induced permeabilization of porcine skin using surface electrodes.

S W Hui, A. Oseroff, S. Hui, 1997, Biophysical journal.

Electrically Enhanced Percutaneous Delivery Of δ-Aminolevulinic Acid Using Electric Pulses and a DC Potential¶

A. Oseroff, S. Hui, Sek Wen Hui, 2002, Photochemistry and photobiology.

Electrically Enhanced Percutaneous Delivery Of δ‐Aminolevulinic Acid Using Electric Pulses and a DC Potential ¶

A. Oseroff, S. Hui, Patricia G. Johnson, 2002 .

Preferential light absorption in atheromas in vitro. Implications for laser angioplasty.

A. Oseroff, J. Parrish, M. Prince, 1986, The Journal of clinical investigation.

HTLV-associated diseases: human retroviral infection and cutaneous T-cell lymphomas.

E. Jaffe, A. Oseroff, K. Fujihara, 1997, Immunological investigations.

Merkel cell carcinoma. Clinical practice guidelines in oncology.

A. Oseroff, N. Lee, J. Grichnik, 2004, Journal of the National Comprehensive Cancer Network : JNCCN.

A simple and efficient approach for the synthesis of fluorinated and nonfluorinated octaethylporphyrin-based benzochlorins with variable lipophilicity, their in vivo tumor uptake, and the preliminary in vitro photosensitizing efficacy.

T. Dougherty, W. Potter, A. Oseroff, 2001, The Journal of organic chemistry.

Photophysical, electrochemical characteristics and cross-linking of STAT-3 protein by an efficient bifunctional agent for fluorescence image-guided photodynamic therapy

A. Oseroff, K. Ohkubo, S. Fukuzumi, 2007, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

Electric-Pulse-Induced Permeabilization and Molecular Transport through Porcine Skin Using Surface Electrodes

A. Oseroff, S. Hui, S. Gallo, 1999 .

An Assay for the Quantitation of Photofrin in Tissues and Fluids

T. Dougherty, A. Oseroff, W. Greco, 1997, Photochemistry and photobiology.

Mitochondrial Toxicity of Cationic Photosensitizers for Photochemotherapy1

Josephine, A. Oseroff, J. Aprille, 2006 .

Simulations of measured photobleaching kinetics in human basal cell carcinomas suggest blood flow reductions during ALA‐PDT

Ken Kang-Hsin Wang, Thomas H Foster, T. Foster, 2009, Lasers in surgery and medicine.

Portable instrument that integrates irradiation with fluorescence and reflectance spectroscopies during clinical photodynamic therapy of cutaneous disease

Thomas H. Foster, Allan R. Oseroff, T. Foster, 2006 .

Advances in Brief Photofrin Photodynamic Therapy Can Significantly Deplete or Preserve Oxygenation in Human Basal Cell Carcinomas during Treatment , Depending on Fluence Rate 1

Michele T. Cooper, B. Henderson, A. Oseroff, 2000 .

Pivotal phase III trial of two dose levels of denileukin diftitox for the treatment of cutaneous T-cell lymphoma.

A. Oseroff, F. Craig, J. Reuben, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Potentiation of ALA-PDT antitumor activity in mice using topical DMXAA

Ulas Sunar, Allan R. Oseroff, David A. Bellnier, 2009, World Congress of the International Photodynamic Association.

Design and construction of a light-delivery system for photodynamic therapy.

W. Potter, A. Oseroff, D. Bellnier, 1999, Medical physics.

Basal cell and squamous cell skin cancers.

A. Oseroff, N. Lee, J. Grichnik, 2010, Journal of the National Comprehensive Cancer Network : JNCCN.

Cationic Triarylmethane Photosensitizers For Selective Photochemotherapy: Victoria Blue-Bo, Victoria Blue-R And Malachite Green

K. Wadwa, S. Smith, A. R. Oseroff, 1989, Other Conferences.